Kuljinder Singh Sodhi

Kuljinder Singh Sodhi

Active Director Director DIN 09377684
DIN 09377684 First appointment Oct 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Kuljinder Singh Sodhi

Data last updated:

Kuljinder Singh Sodhi is a Director at Capital Super Speciality Hospital Private Limited (since 2021). The company operates in Healthcare.

DIN 09377684
Primary Designation Director
Industry Healthcare
First Appointment 27 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Oct 20212021Active

Directorship timeline

Open interactive timeline →
Capital Super Speciality Hospital Private Limited
Premium access

Shareholding and investment profile for Kuljinder Singh Sodhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kuljinder Singh Sodhi

Kuljinder Singh Sodhi currently holds 1 directorship: Capital Super Speciality Hospital Private Limited (Director, since 27 Oct 2021).

Kuljinder Singh Sodhi was first appointed on 27 Oct 2021 as Director at Capital Super Speciality Hospital Private Limited.

The current boards of Kuljinder Singh Sodhi's companies include Harminder Kaur Sodhi (Capital Super Speciality Hospital Private Limited), Jagtar Singh (Capital Super Speciality Hospital Private Limited), Manpreet Jassal (Capital Super Speciality Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available